\
&
Contact us
Partnership website: https://www.kdt-ju.europa.eu/
Electronic and photonic (light based technologies) components, and the software that defines how they work as part of a system, are the Key Digital Technologies. The overarching objective of the KDT partnership is to support the digital transformation of all sectors of the economy and society, make it work for Europe and address the European Green Deal.
By 2030, EU leadership in KDT will reinforce industrial strongholds having seized emerging opportunities to establish technological sovereignty and boost competitiveness.
Draft partnership proposal (January 2021)
Contact
Commission services: CNECT-A3@ec.europa.eu
Partners: AENEAS - Caroline Bedran, ARTEMIS - Jan Lohstroh, EPOSS - Wolfgang Gessner
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
nico.deblauwe@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.